Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps

Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps

Biologicals are becoming increasingly important in the therapeutic landscape of pediatric patients with moderate-to-severe atopic dermatitis (AD). Currently, dupilumab and tralokinumab are registered for the treatment of moderate-to-severe AD, and novel biologicals are expected to follow. Dupilumab...

Full description

Bibliographic Details
Main Authors: Lisa P. van der Rijst, Annet van Royen-Kerkhof, Suzanne G. M. A. Pasmans, Renske Schappin, Marjolein S. de Bruin-Weller, Marlies de Graaf
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Dermatological Treatment
Subjects:
atopic dermatitis
biological therapy
pediatric dermatology
immunomodulating therapy
children
Online Access:http://dx.doi.org/10.1080/09546634.2023.2254567

Internet

http://dx.doi.org/10.1080/09546634.2023.2254567

Similar Items